Cytokinetics Inc. buy Morgan Stanley
Start price
13.02.25
/
50%
€41.00
Target price
13.02.26
€64.45
Performance (%)
35.37%
End price
14.02.26
€55.50
Summary
This prediction ended on 14.02.26 with a price of €55.50. The BUY prediction by Morgan_Stanley for Cytokinetics Inc. saw massive gains of 35.37%. Morgan_Stanley has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cytokinetics Inc. | -2.322% | -2.322% | 114.340% |
| iShares Core DAX® | 3,26 % | 2,07 % | 10,10 % |
| iShares Nasdaq 100 | 5,70 % | -0,60 % | 28,97 % |
| iShares Nikkei 225® | 7,77 % | -4,75 % | 52,09 % |
| iShares S&P 500 | 2,80 % | 2,25 % | 23,75 % |
Comments by Morgan_Stanley for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $67.00 price target on the stock, down previously from $70.00.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Cytokinetics Inc.
Stopped prediction by Morgan_Stanley for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€30.20
04.08.23
04.08.23
€54.39
04.08.24
04.08.24
67.22%
05.08.24
05.08.24
